Meditech’s Expanse determines the risk of Clostridioides difficile and triggers orders when needed, helping with earlier detection, isolation and treatment of C. diff.
“In addition to the mortality attributed to [C. diff], the morbidity cannot be overstated,” said David Byers, MD, senior medical director for infectious diseases at Southern Ohio Medical Center, in an Aug. 30 Meditech news release. “This is a disease that I have seen upend the lives of previously healthy patients through multiple relapses or even colectomies, and often precipitated by antibiotics they didn’t need.”
C. diff incidence and canceled tests have both dropped by about 30 percent since the software was instituted, according to the news release.
“Southern Ohio Medical Center’s commitment to quality improvement really is an investment in their future,” stated Hoda Sayed-Friel, senior vice president for Meditech.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
